With shockwave being a non-invasive treatment, it avoids the risks of having a surgical procedure and has consistently been shown to be incredibly safe (Schmitz et al 2015, Moyer et al 2018) The evidence supports our clinical experience at Complete that shockwave combined with a structured rehabilitation program is the best approach to treating patellar tendinopathy
In REDEFINE 1 , a 68-week, Phase 3a, multicenter, double-blind, placebo- and active-controlled trial, 3,417 adults with overweight or obesity but without diabetes were randomized to CagriSema (cagrilintide 2.4 mg + semaglutide 2.4 mg), semaglutide 2.4 mg, cagrilintide 2.4 mg, or placebo
Occasionally, mild discomfort at the injection site or rare allergic sensitivities may occur
Theyre especially effective for people with low B12 levels or absorption issues
Symptoms can include rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or difficulty breathing